Search

  • HOME
  • Search
Review
2010
Epidemiology of metabolic dysfunction-associated steatotic liver disease
Zobair M. Younossi, Markos Kalligeros, Linda Henry
Clin Mol Hepatol. 2025;31(Suppl):S32-S50.   Published online August 19, 2024
View: 15558   Download: 1,995  Web of Science: 68  Crossref: 71
Original Article
2066
Metabolic dysfunction-associated steatotic liver disease exhibits sex-specific microbial heterogeneity within intestinal compartments
Carlos Jose Pirola, Maria Silvina Landa, Mariano Schuman, Silvia Inés García, Adrian Salatino, Silvia Sookoian
Clin Mol Hepatol. 2025;31(1):179-195.   Published online October 11, 2024
View: 1964   Download: 167  Web of Science: 2  Crossref: 2
Letter to the Editor
1935
Equivalent prevalence and progression of chronic kidney disease in non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease
Hiroyuki Suzuki, Tsubasa Tsutsumi, Machiko Kawaguchi, Keisuke Amano, Takumi Kawaguchi
Clin Mol Hepatol. 2024;30(4):962-964.   Published online May 20, 2024
View: 2129   Download: 110  Web of Science: 2  Crossref: 4
Original Article
1918
Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis
Harry Crane, Guy D. Eslick, Cameron Gofton, Anjiya Shaikh, George Cholankeril, Mark Cheah, Jian-Hong Zhong, Gianluca Svegliati-Baroni, Alessandro Vitale, Beom Kyung Kim, Sang Hoon Ahn, Mi Na Kim, Simone I Strasser, Jacob George
Clin Mol Hepatol. 2024;30(3):436-448.   Published online April 16, 2024
View: 7862   Download: 348  Web of Science: 20  Crossref: 19
Letter to the Editor
1878
Changing from NAFLD to MASLD: Similar prognosis of patients with HCC under atezolizumab/bevacizumab treatment between NAFLD and MASLD
Hiroyuki Suzuki, Shigeo Shimose, Hideki Iwamoto, Takashi Niizeki, Takumi Kawaguchi
Clin Mol Hepatol. 2024;30(2):263-265.   Published online January 18, 2024
View: 3556   Download: 149  Web of Science: 11  Crossref: 11
Correspondence
Correspondence on Letter regarding “Waiting for the changes after the adoption of steatotic liver disease”
Eileen L. Yoon, Dae Won Jun
Clin Mol Hepatol. 2024;30(1):126-128.   Published online November 28, 2023
View: 4279   Download: 54
Review
1759
Liver transplantation for non-alcoholic fatty liver disease: indications and post-transplant management
Sara Battistella, Francesca D’Arcangelo, Marco Grasso, Alberto Zanetto, Martina Gambato, Giacomo Germani, Marco Senzolo, Francesco Paolo Russo, Patrizia Burra
Clin Mol Hepatol. 2023;29(Suppl):S286-S301.   Published online December 28, 2022
View: 8576   Download: 290  Web of Science: 26  Crossref: 32
Special Review
1854
Waiting for the changes after the adoption of steatotic liver disease
Eileen L. Yoon, Dae Won Jun
Clin Mol Hepatol. 2023;29(4):844-850.   Published online September 6, 2023
View: 4271   Download: 188  Web of Science: 37  Crossref: 42
Review
1770
Chronic hepatitis B with concurrent metabolic dysfunction-associated fatty liver disease: Challenges and perspectives
Shang-Chin Huang, Chun-Jen Liu
Clin Mol Hepatol. 2023;29(2):320-331.   Published online February 1, 2023
View: 9129   Download: 483  Web of Science: 45  Crossref: 51
Original Article
1712
Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Michael H. Le, Yee Hui Yeo, Biyao Zou, Scott Barnet, Linda Henry, Ramsey Cheung, Mindie H. Nguyen
Clin Mol Hepatol. 2022;28(4):841-850.   Published online September 19, 2022
View: 11328   Download: 328  Web of Science: 153  Crossref: 162
Original Article
1656
Prevalence trends of non-alcoholic fatty liver disease among young men in Korea: A Korean military population-based cross-sectional study
Jaejun Lee, Taeyun Kim, Hyun Yang, Si Hyun Bae
Clin Mol Hepatol. 2022;28(2):196-206.   Published online January 13, 2022
View: 7473   Download: 225  Web of Science: 22  Crossref: 23
1603
Serum milk fat globule-EGF factor 8 protein as a potential biomarker for metabolic syndrome
Han Ah Lee, Jihwan Lim, Hyung Joon Joo, Young-Sun Lee, Young Kul Jung, Ji Hoon Kim, Hyunggin An, Hyung Joon Yim, Yoon Tae Jeen, Jong Eun Yeon, Do-Sun Lim, Kwan Soo Byun, Yeon Seok Seo
Clin Mol Hepatol. 2021;27(3):463-473.   Published online February 15, 2021
View: 6942   Download: 181  Web of Science: 4  Crossref: 5
Review
1612
From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?
Seong Hee Kang, Yuri Cho, Soung Won Jeong, Seung Up Kim, Jin-Woo Lee, On behalf of Korean NAFLD Study Group
Clin Mol Hepatol. 2021;27(2):257-269.   Published online March 22, 2021
View: 10571   Download: 449  Web of Science: 71  Crossref: 74
Editorial
1588
Probiotics for treatment of nonalcoholic fatty liver disease: It is worth a try
Tian-Yi Ren, Xiao-Yan Li, Jian-Gao Fan
Clin Mol Hepatol. 2021;27(1):83-86.   Published online December 3, 2020
View: 6231   Download: 172  Web of Science: 1  Crossref: 1
Review
1486
Application of transient elastography in nonalcoholic fatty liver disease
Xinrong Zhang, Grace Lai-Hung Wong, Vincent Wai-Sun Wong
Clin Mol Hepatol. 2020;26(2):128-141.   Published online November 8, 2019
View: 17953   Download: 586  Web of Science: 83  Crossref: 89
Original Article
1430
Association between hepatic steatosis and the development of hepatocellular carcinoma in patients with chronic hepatitis B
Yun Bin Lee, Yeonjung Ha, Young Eun Chon, Mi Na Kim, Joo Ho Lee, Hana Park, Kwang-il Kim, Soo-Hwan Kim, Kyu Sung Rim, Seong Gyu Hwang
Clin Mol Hepatol. 2019;25(1):52-64.   Published online October 23, 2018
View: 10118   Download: 365  Web of Science: 87  Crossref: 84
1166
Effect of vitamin E in nonalcoholic fatty liver disease with metabolic syndrome: A propensity score-matched cohort study
Gi Hyun Kim, Jung Wha Chung, Jong Ho Lee, Kyeong Sam Ok, Eun Sun Jang, Jaihwan Kim, Cheol Min Shin, Young Soo Park, Jin-Hyeok Hwang, Sook-Hyang Jeong, Nayoung Kim, Dong Ho Lee, Jin-Wook Kim
Clin Mol Hepatol. 2015;21(4):379-386.   Published online December 24, 2015
View: 13616   Download: 183  Web of Science: 17  Crossref: 14
Association of serum alanine aminotransferase and γ-glutamyltransferase levels within the reference range with metabolic syndrome and nonalcoholic fatty liver disease
Hyo Jeong Oh, Tae Hyeon Kim, Young Woo Sohn, Yong Sung Kim, Yong Reol Oh, Eun Young Cho, So Yeon Shim, Sae Ron Shin, A Lum Han, Seok Jin Yoon, Haak Cheoul Kim
Clin Mol Hepatol. 2011;17(1):27-36.   Published online March 21, 2011
View: 11192   Download: 90  Crossref: 54
Editorial
Liver function tests as indicators of metabolic syndrome
Han Chu Lee
Clin Mol Hepatol. 2011;17(1):9-11.   Published online March 21, 2011
View: 6536   Download: 50  Crossref: 4
3
Nonalcoholic fatty Liver disease as a risk factor of cardiovascular disease; Relation of non-alcoholic fatty Liver disease to carotid atherosclerosis
Su-Yeon Choi, M.D., Donghee Kim, M.D., Jin Hwa Kang, M.D. Min Jung Park, M.D., Young Sun Kim, M.D., Seon Hee Lim, M.D., Chung Hyeon Kim, M.D., Hyo-Suk Lee, M.D.
Clin Mol Hepatol. 2008;14(1):77-88.   Published online March 20, 2008
View: 7276   Download: 131  Crossref: 30
1
Nonalcoholic fatty Liver disease as a risk factor of cardiovascular disease
Moon Young Kim , Soon Koo Baik
Clin Mol Hepatol. 2008;14(1):1-3.   Published online March 20, 2008
View: 5477   Download: 67  Crossref: 2
5
Nonalcoholic Steatohepatitis
So-Young Jin
Clin Mol Hepatol. 2006;12(3):455-459.   Published online January 1, 2000
View: 2914   Download: 21
3
The Prevalence of Metabolic Syndrome in Patients with Nonalcoholic Fatty Liver Disease
Ki Won Moon, M.D., Joung Muk Leem, M.D., Sang Seok Bae, M.D., Ki Man Lee, M.D., Seok Hyung Kim, M.D.*, Hee Bok Chae, M.D., Seon Mee Park, M.D. and Sei Jin Youn, M.D.
Clin Mol Hepatol. 2004;10(3):197-206.   Published online January 1, 1970
View: 3525   Download: 59
Letter to the Editor
What is new in the 2024 Chinese guidelines for fatty liver disease?
Rui-Xu Yang, Vincent Wai-Sun Wong, Jian-Gao Fan
Received December 27, 2024  Accepted January 18, 2025  
View: 561   Download: 56
1 |

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X


Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: cmh_journal@ijpnc.com
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 2936
TOTAL : 2790627
Close layer